Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, May 2, 2023.
Customized orthopedics is a growing trend in the medical device industry. Zimmer Biomet’s recent acquisition of Ossis underscores that trend toward personalized medicine. Fast Five hosts Danielle Kirsh and Sean Whooley give an inside look at the acquisition and how it will complement the orthopedic giant’s vast portfolio.
Chronic venous insufficiency (CVI) happens when a patient’s blood vessels in the lower limbs do not effectively pump blood back to the heart, causing valves in the leg veins to become damaged and less effective. Cook Medical wants to fix that. Whooley details the company’s initiation of its venous valve trial and how its device aims to reduce the occurrence of CVI.
Home heart monitoring could get easier with the recent FDA clearance of a smart toilet seat. Hear from the Fast Five hosts how the smart seat works and when potential users can expect to see it on the market.
Continuous glucose monitoring innovations are rapidly gaining regulatory milestones across the globe to assist people living with diabetes. Whooley outlines Abbott’s recent authorization in the U.K. for its FreeStyle Libre 3 and what this means for people with diabetes in Europe.
Medtronic was one of the first companies in the world to make a pacemaker. This week, the company won an FDA nod for its next generation of leadless pacemakers. The Fast Five hosts discuss how the leadless pacemakers work and what sets them apart from previous iterations.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.